<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Biperiden,Biperiden.png,ATC code N04,Adverse drug reaction,Anatomical Therapeutic Chemical Classification System,Anticholinergic,Antihistamine,Antipsychotic,Anxiety,Atropine,Australia" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Biperiden - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Biperiden</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    	    <!-- start content -->
	    <table id="drugInfoBox" style="float: right; clear: right; margin: 0 0 0.5em 1em; background: #ffffff;" class="toccolours" border="0" cellpadding="1" align="right" width="280">
<tr>
<td align="center" colspan="2"><a href="../../../b/i/p/Image%7EBiperiden.svg_c279.html" class="image" title=""><img src="../../../upload/shared/thumb/8/8b/Biperiden.svg/220px-Biperiden.svg.png" alt="" width="220" height="183" longdesc="../../../b/i/p/Image%7EBiperiden.svg_c279.html" /></a></td>
</tr>
<tr>
<td align="center" colspan="2">
<div style="font-size:medium; line-height:167%;">Biperiden</div>
</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Systematic (<a href="../../../i/n/t/International_Union_of_Pure_and_Applied_Chemistry_nomenclature_efd4.html" title="International Union of Pure and Applied Chemistry nomenclature">IUPAC</a>) name</b></td>
</tr>
<tr>
<td bgcolor="#EEEEEE" style="text-align: center; vertical-align: top;" colspan="2"><span style="font-size:11px">1-(5-bicyclo[2.2.1]hept-2-enyl)-1-phenyl-3-(1-piperidyl)<br />
propan-1-ol</span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Identifiers</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" width="90"><a href="../../../c/a/s/CAS_registry_number_4b20.html" title="CAS registry number">CAS number</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?term=514-65-8&amp;rn=1" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?term=514-65-8&amp;rn=1" rel="nofollow">514-65-8</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../a/n/a/Anatomical_Therapeutic_Chemical_Classification_System_186e.html" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></td>
<td bgcolor="#EEEEEE"><a href="../../../a/t/c/ATC_code_N04_47b7.html" title="ATC code N04">N04</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=N04AA02" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=N04AA02" rel="nofollow">AA02</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../p/u/b/PubChem_a50b.html" title="PubChem">PubChem</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=2381" class="external text" title="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=2381" rel="nofollow">2381</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../d/r/u/DrugBank_2050.html" title="DrugBank">DrugBank</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=APRD00725" class="external text" title="http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=APRD00725" rel="nofollow">APRD00725</a></span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Chemical data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../c/h/e/Chemical_formula.html" title="Chemical formula">Formula</a></td>
<td bgcolor="#EEEEEE"><a href="../../../c/a/r/Carbon.html" title="Carbon"><span style="color: rgb(000,000,000); font-weight: bold;">C</span></a><sub>21</sub><a href="../../../h/y/d/Hydrogen.html" title="Hydrogen"><span style="color: rgb(77,77,77); font-weight: bold;">H</span></a><sub>29</sub><a href="../../../n/i/t/Nitrogen.html" title="Nitrogen"><span style="color: rgb(0,0,128); font-weight: bold;">N</span></a><a href="../../../o/x/y/Oxygen.html" title="Oxygen"><span style="color: rgb(116,35,35); font-weight: bold;">O</span></a><sup>&#160;</sup></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../m/o/l/Molecular_mass.html" title="Molecular mass">Mol. mass</a></td>
<td bgcolor="#EEEEEE">311.461 g/mol</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Pharmacokinetic data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../b/i/o/Bioavailability.html" title="Bioavailability">Bioavailability</a></td>
<td bgcolor="#EEEEEE">33 ± 5% (oral)</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../p/l/a/Plasma_protein_binding.html" title="Plasma protein binding">Protein binding</a></td>
<td bgcolor="#EEEEEE">60%</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../d/r/u/Drug_metabolism.html" title="Drug metabolism">Metabolism</a></td>
<td bgcolor="#EEEEEE"><a href="../../../l/i/v/Liver.html" title="Liver">Hepatic</a> <a href="../../../h/y/d/Hydroxylation.html" title="Hydroxylation">hydroxylation</a></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../b/i/o/Biological_half-life.html" title="Biological half-life">Half life</a></td>
<td bgcolor="#EEEEEE">18 to 24 hours</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../e/x/c/Excretion.html" title="Excretion">Excretion</a></td>
<td bgcolor="#EEEEEE"><a href="../../../k/i/d/Kidney.html" title="Kidney">Renal</a></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Therapeutic considerations</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../p/r/e/Pregnancy_category.html" title="Pregnancy category">Pregnancy cat.</a></td>
<td bgcolor="#EEEEEE">
<p>B2<small>(<a href="../../../a/u/s/Australia.html" title="Australia">AU</a>)</small> C<small>(<a href="../../../u/n/i/United_States_09d4.html" title="United States">US</a>)</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../r/e/g/Regulation_of_therapeutic_goods.html" title="Regulation of therapeutic goods">Legal status</a></td>
<td bgcolor="#EEEEEE">
<p><a href="../../../p/r/e/Prescription_drug.html" title="Prescription drug"><span class="Unicode">℞</span><small>-only</small></a><small>(<a href="../../../u/n/i/United_States_09d4.html" title="United States">US</a>)</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../r/o/u/Route_of_administration.html" title="Route of administration">Routes</a></td>
<td bgcolor="#EEEEEE">Oral, <a href="../../../i/n/t/Intramuscular_injection.html" title="Intramuscular injection">IM</a>, <a href="../../../i/n/t/Intravenous_therapy.html" title="Intravenous therapy">IV</a></td>
</tr>
</table>
<p><b>Biperiden</b> is an antiparkinsonian agent of the <a href="../../../a/n/t/Anticholinergic.html" title="Anticholinergic">anticholinergic</a> type. The original brand name - still existing - is <b>Akineton®</b>, manufactured by BASF/Knoll Pharma. Generics are available worldwide.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Pharmacokinetics"><span class="tocnumber">1</span> <span class="toctext">Pharmacokinetics</span></a></li>
<li class="toclevel-1"><a href="#Pharmacology"><span class="tocnumber">2</span> <span class="toctext">Pharmacology</span></a></li>
<li class="toclevel-1"><a href="#Uses"><span class="tocnumber">3</span> <span class="toctext">Uses</span></a></li>
<li class="toclevel-1"><a href="#Contraindications_and_cautions"><span class="tocnumber">4</span> <span class="toctext">Contraindications and cautions</span></a></li>
<li class="toclevel-1"><a href="#Special_patient_groups"><span class="tocnumber">5</span> <span class="toctext">Special patient groups</span></a>
<ul>
<li class="toclevel-2"><a href="#Pregnancy_and_lactation"><span class="tocnumber">5.1</span> <span class="toctext">Pregnancy and lactation</span></a></li>
<li class="toclevel-2"><a href="#Pediatric_patients"><span class="tocnumber">5.2</span> <span class="toctext">Pediatric patients</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Side_effects"><span class="tocnumber">6</span> <span class="toctext">Side effects</span></a></li>
<li class="toclevel-1"><a href="#Interactions"><span class="tocnumber">7</span> <span class="toctext">Interactions</span></a></li>
<li class="toclevel-1"><a href="#Dosage"><span class="tocnumber">8</span> <span class="toctext">Dosage</span></a></li>
<li class="toclevel-1"><a href="#Overdose"><span class="tocnumber">9</span> <span class="toctext">Overdose</span></a></li>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">10</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1"><a href="#Notes"><span class="tocnumber">11</span> <span class="toctext">Notes</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">12</span> <span class="toctext">References</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Pharmacokinetics" id="Pharmacokinetics"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/p/Biperiden.html" title="Edit section: Pharmacokinetics">edit</a>]</span> <span class="mw-headline">Pharmacokinetics</span></h2>
<p>The oral <a href="../../../b/i/o/Bioavailability.html" title="Bioavailability">bioavailability</a> is only 33 +/- 5% due to extensive <a href="../../../f/i/r/First_pass_effect.html" title="First pass effect">first-pass metabolization</a>. In young, healthy volunteers peak plasma concentrations following an oral single dose of 4mg in immediate release form are reached after 1.5 hours. The <a href="../../../e/l/i/Elimination_half-life.html" title="Elimination half-life">elimination half-life</a> has been determined as 18.4 hours, and may be prolonged in geriatric patients. After <a href="../../../i/n/t/Intravenous_therapy.html" title="Intravenous therapy">IV</a> dosing of 4mg the elimination half-life is approximately 24 hours.</p>
<p><a name="Pharmacology" id="Pharmacology"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/p/Biperiden.html" title="Edit section: Pharmacology">edit</a>]</span> <span class="mw-headline">Pharmacology</span></h2>
<p>Biperiden has an <a href="../../../a/t/r/Atropine.html" title="Atropine">atropine</a>-like blocking effect on all peripheral structures which are parasympathetic-innervated (e.g. cardiovascular and visceral organs). It also has a prominent central blocking effect on <a href="../../../m/u/s/Muscarinic_receptor.html#Receptor_Subtype_M1" title="Muscarinic receptor">M1 receptors</a>.</p>
<p><a name="Uses" id="Uses"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/p/Biperiden.html" title="Edit section: Uses">edit</a>]</span> <span class="mw-headline">Uses</span></h2>
<p>Biperiden is used for the adjunctive treatment of all forms of <a href="../../../p/a/r/Parkinson%27s_disease.html" title="Parkinson's disease">Parkinson's disease</a> (postencephalitic, idiopathic, and arteriosclerotic). It seems to exert better effects in the postencephalitic and idiopathic than in the arteriosclerotic type. Biperiden is also commonly used to improve parkinsonian signs and symptoms related to <a href="../../../a/n/t/Antipsychotic.html" title="Antipsychotic">antipsychotic</a> drug therapy. It relieves muscle rigidity, reduces abnormal sweating and salivation, improves abnormal gait, and to lesser extend, tremor.</p>
<p><a name="Contraindications_and_cautions" id="Contraindications_and_cautions"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/p/Biperiden.html" title="Edit section: Contraindications and cautions">edit</a>]</span> <span class="mw-headline">Contraindications and cautions</span></h2>
<ul>
<li>Hypersensitivity to biperiden</li>
<li>Narrow angle <a href="../../../g/l/a/Glaucoma.html" title="Glaucoma">glaucoma</a></li>
<li>Functional obstruction of the <a href="../../../g/a/s/Gastrointestinal_tract.html" title="Gastrointestinal tract">GI tract</a></li>
<li><a href="../../../i/l/e/Ileus.html" title="Ileus">Ileus</a></li>
<li>Caution&#160;: Patients with obstructive diseases of the urogenital tract, patients with a known history of seizures and those with potentially dangerous <a href="../../../t/a/c/Tachycardia.html" title="Tachycardia">tachycardia</a></li>
</ul>
<p><a name="Special_patient_groups" id="Special_patient_groups"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/p/Biperiden.html" title="Edit section: Special patient groups">edit</a>]</span> <span class="mw-headline">Special patient groups</span></h2>
<p><a name="Pregnancy_and_lactation" id="Pregnancy_and_lactation"></a></p>
<h3><span class="editsection">[<a href="../../../b/i/p/Biperiden.html" title="Edit section: Pregnancy and lactation">edit</a>]</span> <span class="mw-headline">Pregnancy and lactation</span></h3>
<ul>
<li>Pregnancy&#160;: In animal studies biperiden had no embryo- or fetotoxic effects. There is no sufficient clinical data on pregnant women. The drug should therefore be used cautiously during pregnancy.</li>
</ul>
<ul>
<li>Lactation&#160;: Biperiden is found in the milk of lactating women. No sufficient clinical data exists regarding effects for the newborns. Additionally, biperiden may decrease maternal milk production. It is therefore recommended that biperiden is not used during lactation.</li>
</ul>
<p><a name="Pediatric_patients" id="Pediatric_patients"></a></p>
<h3><span class="editsection">[<a href="../../../b/i/p/Biperiden.html" title="Edit section: Pediatric patients">edit</a>]</span> <span class="mw-headline">Pediatric patients</span></h3>
<p>Children and adolescents aged 1 year and older may be treated. The clinical experience is mainly on the shortterm treatment of acute drug induced dystonic reactions. Doses should be reduced according to the weight of the patients.</p>
<p><a name="Side_effects" id="Side_effects"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/p/Biperiden.html" title="Edit section: Side effects">edit</a>]</span> <span class="mw-headline">Side effects</span></h2>
<p>Dose-dependent <a href="../../../a/d/v/Adverse_drug_reaction.html" title="Adverse drug reaction">side effects</a> are frequent. Particularly geriatric patients may react with confusional states or develop <a href="../../../d/e/l/Delirium.html" title="Delirium">delirium</a>.</p>
<ul>
<li>CNS&#160;: <a href="../../../d/r/o/Drowsiness.html" title="Drowsiness">Drowsiness</a>, <a href="../../../v/e/r/Vertigo_%28medical%29.html" title="Vertigo (medical)">vertigo</a>, <a href="../../../h/e/a/Headache.html" title="Headache">headache</a>, and <a href="../../../d/i/z/Dizziness.html" title="Dizziness">dizziness</a> are frequent. With high doses nervousness, agitation, <a href="../../../a/n/x/Anxiety.html" title="Anxiety">anxiety</a>, delirium, and confusion are noted. Biperiden may be abused due to a short acting mood-elevating and euphoriant effect. The normal sleep architecture may be altered (<a href="../../../r/e/m/REM_sleep_0a73.html" title="REM sleep">REM sleep</a> depression). Biperiden may lower the seizure-threshold. Some instances of dementia have been noted to correllate with chronic administration of <a href="../../../a/n/t/Anticholinergic.html" title="Anticholinergic">anticholinergic</a> medications such as Biperiden for <a href="../../../p/a/r/Parkinson%27s_disease.html" title="Parkinson's disease">Parkinson's disease</a>.<sup id="_ref-0" class="reference"><a href="#_note-0" title="">[1]</a></sup></li>
<li>Peripheral side effects&#160;: Blurred vision, dry mouth, impaired sweating, abdominal discomfort, and obstipation are frequent. Tachycardia may be noted. Allergic skin reactions may occur. Parenteral use may cause orthostatic hypotension.</li>
<li>Eyes&#160;: Biperiden causes <a href="../../../m/y/d/Mydriasis.html" title="Mydriasis">mydriasis</a> with or without <a href="../../../p/h/o/Photophobia.html" title="Photophobia">photophobia</a>. It may precipitate narrow angle glaucoma.</li>
</ul>
<p><a name="Interactions" id="Interactions"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/p/Biperiden.html" title="Edit section: Interactions">edit</a>]</span> <span class="mw-headline">Interactions</span></h2>
<ul>
<li>Other anticholinergic drugs (e.g. spasmolytics, <a href="../../../a/n/t/Antihistamine.html" title="Antihistamine">antihistamines</a>, TCAs)&#160;: Side effects of biperiden may be increased.</li>
<li><a href="../../../q/u/i/Quinidine.html" title="Quinidine">Quinidine</a>&#160;: Increased anticholinergic action (particular on AV conduction).</li>
<li>Antipsychotics&#160;: Long term use of biperiden may mask or increase the risk of <a href="../../../t/a/r/Tardive_dyskinesia.html" title="Tardive dyskinesia">tardive dyskinesia</a>.</li>
<li><a href="../../../p/e/t/Pethidine.html" title="Pethidine">Pethidine</a> (meperidine)&#160;: Central effects and side effects of pethidine may be increased.</li>
<li><a href="../../../m/e/t/Metoclopramide.html" title="Metoclopramide">Metoclopramide</a>&#160;: Action of metoclopramide is decreased.</li>
<li>Alcohol&#160;: Risk of serious intoxication.</li>
</ul>
<p><a name="Dosage" id="Dosage"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/p/Biperiden.html" title="Edit section: Dosage">edit</a>]</span> <span class="mw-headline">Dosage</span></h2>
<p>Strictly individual. Oral, and in some countries, IV and <a href="../../../i/n/t/Intramuscular_injection.html" title="Intramuscular injection">IM</a> use is possible. The usual oral daily doses are between 2 and 16mg. If possible, patients should be started with a low initial dose which is increased slowly.</p>
<p><a name="Overdose" id="Overdose"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/p/Biperiden.html" title="Edit section: Overdose">edit</a>]</span> <span class="mw-headline">Overdose</span></h2>
<p>Biperiden mimics an atropine intoxication with mydriasis, dryness of mucous membranes, red face, atonic states of bowels and bladder, and <a href="../../../h/y/p/Hyperthermia.html" title="Hyperthermia">hyperthermia</a> in high doses. Central consequences are agitation, confusion, and hallucinations. An untreated overdose may be fatal, particular in children. Premortal signs are respiratory depression and cardiac arrest. A specific antagonist is <a href="../../../p/h/y/Physostigmine.html" title="Physostigmine">physostigmine</a> which combines a peripheral and a central action. <a href="../../../c/a/r/Carbachol.html" title="Carbachol">Carbachol</a> can be used to treat atonic bowels and bladder. The vital functions should be monitored and stabilized. It may be necessary to treat hyperthermia with cooling blankets.</p>
<p><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/p/Biperiden.html" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<p>Biperiden was synthesized by the German chemist W. Klavehn from Knoll AG, Germany. In March 1953 a patent was applied for in Germany and subsequently in many other countries.</p>
<p><a name="Notes" id="Notes"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/p/Biperiden.html" title="Edit section: Notes">edit</a>]</span> <span class="mw-headline">Notes</span></h2>
<div class="references-small">
<ol class="references">
<li id="_note-0"><b><a href="#_ref-0" title="">^</a></b> <cite style="font-style:normal">Nishiyama K, Mizuno T, Sakuta M, Kurisaki H (1993). "Chronic dementia in Parkinson's disease treated by anticholinergic agents. Neuropsychological and neuroradiological examination.". <i>Adv Neurol</i> <b>60</b>: 479-83. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8420174" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8420174">PMID 8420174</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Chronic+dementia+in+Parkinson%27s+disease+treated+by+anticholinergic+agents.+Neuropsychological+and+neuroradiological+examination.&amp;rft.title=Adv+Neurol&amp;rft.jtitle=Adv+Neurol&amp;rft.date=1993&amp;rft.volume=60&amp;rft.au=Nishiyama+K%2C+Mizuno+T%2C+Sakuta+M%2C+Kurisaki+H&amp;rft.pages=479-83">&#160;</span></li>
</ol>
</div>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/p/Biperiden.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<ul>
<li>AHFS database online</li>
<li>Scientific Information on Akineton (Swiss)</li>
<li>Arnd Barocka, Psychopharmakotherapie in Klinik und Praxis, Schattauer-Verlag , 1998 (German language)</li>
<li><cite class="book" style="font-style:normal">Albers, Lawrence; Rhoda Hahn, Christopher Reist (2001-2002). <i>Handbook of Psychiatric Drugs</i>. Laguna Hills, California: Current Clinical Strageties.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Handbook+of+Psychiatric+Drugs&amp;rft.title=Handbook+of+Psychiatric+Drugs&amp;rft.aulast=Albers&amp;rft.aufirst=Lawrence&amp;rft.date=2001-2002&amp;rft.pub=Current+Clinical+Strageties&amp;rft.place=Laguna+Hills%2C+California">&#160;</span></li>
</ul>

<!-- 
Pre-expand include size: 34229 bytes
Post-expand include size: 10330 bytes
Template argument size: 3708 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../b/i/p/Biperiden.html">http://en.wikipedia.org../../../b/i/p/Biperiden.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Category</a>: <span dir='ltr'><a href="../../../a/n/t/Category%7EAntiparkinsonian_agents_71bb.html" title="Category:Antiparkinsonian agents">Antiparkinsonian agents</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../b/i/p/Biperiden.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../b/i/p/Talk%7EBiperiden_9205.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Biperiden">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../de/b/i/p/Biperiden.html">Deutsch</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 03:41, 11 March 2007 by Anonymous user(s) of Wikipedia. Based on work by Wikipedia user(s) <a href="../../../f/v/a/User%7EFvasconcellos_4804.html" title="User:Fvasconcellos">Fvasconcellos</a>, <a href="../../../b/l/u/User%7EBluebot_e595.html" title="User:Bluebot">Bluebot</a>, <a href="../../../u/t/h/User%7EUthbrian_6843.html" title="User:Uthbrian">Uthbrian</a>, <a href="../../../t/h/e/User%7EThe_JPS_fb9e.html" title="User:The JPS">The JPS</a>, Ifnord, <a href="../../../r/i/c/User%7ERich_Farmbrough_7642.html" title="User:Rich Farmbrough">Rich Farmbrough</a>, <a href="../../../s/c/r/User%7EScranchuse_afd2.html" title="User:Scranchuse">Scranchuse</a>, <a href="../../../s/m/a/User%7ESmackBot_cc7a.html" title="User:SmackBot">SmackBot</a>, <a href="../../../a/s/p/User%7EAsparagus_6351.html" title="User:Asparagus">Asparagus</a> and KlausFr.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
